What Is Immunology? Research Areas, Funding, and Career Paths

Immunology is the branch of biomedical science that studies the immune system — the network of cells, tissues, organs, and signaling molecules that distinguishes the body’s own healthy tissue from pathogens, damaged cells, and other threats, and mounts a coordinated response against them. It is one of the largest and most translationally consequential fields in the life sciences: nearly every major area of modern medicine, from vaccine development and cancer treatment to organ transplantation and the management of chronic autoimmune and allergic disease, rests on immunological research.

This guide answers “what is immunology” in depth, then adds the research-administration layer that a working scientist, program officer, or research-support professional actually needs: who funds the field, what methods and equipment the work depends on, and how people train into it.

What Is Immunology?

Immunology studies how organisms detect and respond to things that don’t belong — bacteria, viruses, fungi, parasites, transplanted tissue, and the body’s own cells when they turn cancerous or become damaged — while normally leaving healthy self tissue alone. That last clause is the field’s central and hardest problem: an immune system has to be aggressive enough to clear real threats but restrained enough not to attack the body it belongs to. Most of what immunologists study is, at bottom, an investigation of how that balance is struck, and what happens when it fails.

Innate and adaptive immunity

Immunologists conventionally divide the immune system into two interacting arms:

• Innate immunity is the body’s fast, non-specific first line of defense — physical barriers (skin, mucosa), and cells such as neutrophils, macrophages, dendritic cells, and natural killer (NK) cells that recognize broad molecular patterns shared by many pathogens and respond within minutes to hours. It does not improve with repeated exposure to the same threat.
• Adaptive immunity is slower to activate (days) but highly specific and, critically, has memory. It centers on two lymphocyte populations: B cells, which mature into plasma cells that secrete antigen-specific antibodies, and T cells, which include helper T cells (which coordinate the response) and cytotoxic T cells (which directly kill infected or abnormal cells). Because adaptive immunity retains a memory of prior encounters, a second exposure to the same pathogen triggers a faster, stronger response — the principle vaccines are built on.

The two arms are not separate systems running in parallel; innate immune cells (particularly dendritic cells) present antigen to and activate the adaptive response, and adaptive immunity in turn recruits and directs innate effector cells. A large share of immunology research is specifically about that handoff and feedback between the two.

Core objects of study

Beyond the innate/adaptive framework, immunology examines:

• Antigens and antibodies — the molecular basis of specific recognition, including how B cells generate the enormous diversity of antibody specificities needed to recognize almost any possible molecular shape.
• The major histocompatibility complex (MHC), called HLA in humans — the molecular system that presents fragments of proteins on a cell’s surface so T cells can inspect them, and the basis of both immune recognition and organ-transplant compatibility.
• Cytokines and chemokines — the signaling proteins immune cells use to communicate, recruit each other, and regulate the intensity and character of a response.
• The complement system — a cascade of blood proteins that tags pathogens for destruction and can lyse microbial cells directly.
• Immune tolerance — the mechanisms (central tolerance in the thymus and bone marrow, peripheral tolerance via regulatory T cells and other checks) that normally prevent the immune system from attacking the body’s own tissue, and what goes wrong in autoimmune disease when tolerance fails.
• Primary and secondary lymphoid organs — where immune cells develop (bone marrow, thymus) and where they encounter antigen and mount responses (lymph nodes, spleen, mucosa-associated lymphoid tissue).

How immunology relates to neighboring disciplines

Immunology sits at a crossroads of several other fields rather than in isolation from them:

• Microbiology and virology study the pathogens themselves; immunology studies the host’s response to them. The two are constantly in dialogue — understanding a pathogen’s biology shapes vaccine and therapeutic design, and understanding host immunity shapes how pathogens are expected to evolve and evade it.
• Molecular and cell biology supply the mechanistic toolkit — signal transduction, gene regulation, protein structure — that explains how an immune cell actually behaves once it recognizes a threat.
• Genetics intersects heavily through immunogenetics: HLA typing, the genetic basis of primary immunodeficiencies, and genome-wide association studies that have identified many of the risk variants underlying autoimmune disease.
• Pharmacology overlaps in immunopharmacology — the design of vaccines, monoclonal antibodies, checkpoint inhibitors, and immunosuppressive drugs, all of which act directly on immune targets.
• Oncology now depends heavily on tumor immunology, since many of the most significant recent advances in cancer treatment (checkpoint inhibitors, CAR-T cell therapy) work by redirecting the immune system against cancer rather than attacking the tumor directly.

Major Subfields of Immunology

Immunology is broad enough that most working immunologists specialize. The major subfields include:

• Innate immunology — pattern-recognition receptors, inflammation, and the biology of neutrophils, macrophages, dendritic cells, and NK cells.
• Cellular and humoral immunology — T cell and B cell biology, antibody generation and affinity maturation, and adaptive immune memory.
• Immunogenetics — the genetic basis of immune variation, HLA typing and its role in transplant matching and disease susceptibility.
• Clinical immunology and allergy — the diagnosis and treatment of immune-mediated disease in patients, including primary immunodeficiencies, allergic and hypersensitivity reactions, and autoimmune disease.
• Tumor immunology / immuno-oncology — how tumors evade and suppress immune attack, and how to therapeutically re-activate the immune system against cancer.
• Transplant immunology — the mechanisms of graft rejection and graft-versus-host disease, and how immunosuppressive regimens are designed around them.
• Mucosal immunology — immune activity at barrier surfaces (gut, lung, skin), including its interaction with the resident microbiome.
• Vaccine immunology (vaccinology) — how to elicit durable, protective adaptive immunity through deliberate antigen exposure, and how to measure that protection.
• Neuroimmunology — the bidirectional relationship between the nervous and immune systems, relevant to conditions such as multiple sclerosis.
• Comparative and veterinary immunology — immune function across non-human species, both for animal health and as a source of model systems for human immunology.
• Systems immunology — a newer, computationally driven subfield that models the immune system as a whole using high-dimensional data (single-cell sequencing, mass cytometry) rather than one cell type or pathway at a time.

Who Funds Immunology Research

Immunology research in the United States is funded primarily through federal biomedical research agencies, with private foundations playing a significant supporting role in specific subfields.

Federal funding

Within the National Institutes of Health (NIH), the National Institute of Allergy and Infectious Diseases (NIAID) is the institute most directly organized around immunology — its mission explicitly covers basic and clinical immunology alongside infectious disease and allergy research, and it is the largest single federal funder of the field. Because immunology is fundamental to so many disease areas, several other NIH institutes fund immunology research within their own disease scope rather than as a standalone category: the National Cancer Institute (NCI) funds tumor immunology and immuno-oncology, the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) funds autoimmune and rheumatic disease immunology, and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) funds the autoimmune biology of type 1 diabetes. Investigators should generally expect the appropriate institute to track the disease application of the work rather than the word “immunology” itself.

Outside NIH, the National Science Foundation’s Directorate for Biological Sciences funds basic, non-clinical immunology research — particularly comparative and mechanistic immune-system biology in non-human model organisms — complementing NIH’s disease- and human-health-oriented mandate.

Private and philanthropic funders

Several private foundations are genuinely notable, active funders in immunology specifically: the Cancer Research Institute is a nonprofit organization dedicated specifically to funding cancer immunotherapy and tumor immunology research. The Howard Hughes Medical Institute (HHMI) funds individual investigators across biomedical science through its Investigator Program, a substantial number of whom work in immunology. The Bill & Melinda Gates Foundation is a major funder of vaccine immunology and global-health-focused immune research. Disease-specific foundations such as those focused on type 1 diabetes and other autoimmune conditions also fund immunology research tied to their specific disease mission. This is a representative, not exhaustive, list — the practical takeaway for a researcher is that funding tends to follow either the immune mechanism itself (NIAID, NSF) or the disease application (NCI, NIAMS, NIDDK, and disease-specific foundations), and a grant strategy usually needs to account for both angles.

Research Methods and Tools

Immunology is a wet-lab-intensive field built around a recurring set of core techniques:

• Flow cytometry — the workhorse technique for identifying and quantifying immune cell populations by their surface markers, and for cell sorting when a specific population needs to be isolated for downstream analysis.
• ELISA and related immunoassays — used to detect and quantify specific antibodies, cytokines, or other proteins in a sample.
• Immunohistochemistry and immunofluorescence — used to visualize where specific immune cells or molecules are located within tissue.
• Animal models, especially genetically engineered mice (knockout, knock-in, and humanized strains), remain central to studying immune function in a whole-organism context that cell culture cannot replicate.
• Single-cell sequencing and mass cytometry (CyTOF) — newer high-dimensional profiling techniques that let researchers characterize immune cell states and heterogeneity at a resolution not possible with earlier bulk methods, and that underpin the systems-immunology subfield above.
• Cell culture and PBMC (peripheral blood mononuclear cell) preparation — the standard starting point for working with human immune cells ex vivo.
• ELISPOT and tetramer staining — specialized assays for detecting and quantifying antigen-specific T cell responses.

CASRAI covers several of these methods in dedicated technical guides: see how flow cytometry works, PBMC preparation and staining, ELISA protocol basics, and what single-cell sequencing costs.

Career and Training Pathways

Most research-track immunologists hold a PhD in immunology, microbiology and immunology, or a related biomedical field, typically following a structure common across the biomedical sciences: several years of coursework and lab rotations, qualifying exams, a dissertation built around original research, and often one or more postdoctoral fellowships before an independent faculty or industry research position. Clinical immunologists and allergists instead train through medical school followed by residency (commonly internal medicine or pediatrics) and a subspecialty fellowship in allergy and immunology, then board certification in that subspecialty. Combined MD/PhD training is common for those aiming at physician-scientist roles that bridge clinical immunology and laboratory research.

The American Association of Immunologists (AAI), which publishes The Journal of Immunology, is the principal professional society for immunologists in the United States. The International Union of Immunological Societies (IUIS) is the umbrella body coordinating national immunology societies worldwide. Both are useful entry points for trainees looking for conferences, funding announcements, and career resources specific to the field.

For the funding-application side of an immunology career, CASRAI’s guides on the NIAID payline and the HHMI Gilliam Fellowship cover two of the funding mechanisms most relevant to immunology trainees specifically.

Frequently Asked Questions

What is immunology in simple terms?

Immunology is the study of how the body defends itself against infection and disease while normally leaving its own healthy tissue alone — and what happens when that system misfires, as in allergy, autoimmune disease, or immunodeficiency.

What is the difference between immunology and microbiology?

Microbiology studies the microorganisms themselves (bacteria, viruses, fungi, parasites); immunology studies how the host organism detects and responds to them. Many researchers work across both, since host and pathogen biology are studied in constant relation to each other.

What is the difference between innate and adaptive immunity?

Innate immunity is fast, non-specific, and does not improve with repeated exposure. Adaptive immunity is slower to activate but highly specific and retains memory, so a second exposure to the same pathogen triggers a faster, stronger response — the basis for how vaccines work.

What jobs can you get with an immunology background?

Academic and industry research (including biotech and pharmaceutical R&D), clinical allergy/immunology practice (for MDs), vaccine and biologics development, public health and infectious disease work, and research-administration or grants-management roles supporting immunology labs and programs.

Is immunology a good research field to enter right now?

Immunology remains one of the most heavily funded and translationally active areas of biomedical research, driven in large part by continued advances in immuno-oncology, vaccine science, and autoimmune disease treatment — but like most biomedical research fields, funding is competitive and typically requires a PhD or MD/PhD for an independent research career.

Related CASRAI Guides

This guide is part of a series on major scientific disciplines. See the branches of science hub guide for the full set, including what is virology, what is genetics, and what is pharmacology — three disciplines immunology overlaps with directly. For the field’s data infrastructure, see CASRAI’s guide to ImmPort, NIAID’s immunology data repository.